148 related articles for article (PubMed ID: 30439366)
21. [Effects and mechanism on anti-leukemic activity of cytokine-induced killer cells with an endogenous expression of interleukin-21].
Zhao N; Zhao MF; Rajbhandary S; Lu WY; Zhu HB; Ma L; You Q; Xiao X; Deng Q; Li YM
Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(4):293-9. PubMed ID: 23578511
[TBL] [Abstract][Full Text] [Related]
22. Polarization of Valpha24+ Vbeta11+ natural killer T cells of healthy volunteers and cancer patients using alpha-galactosylceramide-loaded and environmentally instructed dendritic cells.
van der Vliet HJ; Molling JW; Nishi N; Masterson AJ; Kölgen W; Porcelli SA; van den Eertwegh AJ; von Blomberg BM; Pinedo HM; Giaccone G; Scheper RJ
Cancer Res; 2003 Jul; 63(14):4101-6. PubMed ID: 12874013
[TBL] [Abstract][Full Text] [Related]
23. Deficiency of pulmonary Valpha24 Vbeta11 natural killer T cells in corticosteroid-naïve sarcoidosis patients.
Korosec P; Rijavec M; Silar M; Kern I; Kosnik M; Osolnik K
Respir Med; 2010 Apr; 104(4):571-7. PubMed ID: 19954940
[TBL] [Abstract][Full Text] [Related]
24. Modulation of human Valpha24(+)Vbeta11(+) NKT cells by age, malignancy and conventional anticancer therapies.
Crough T; Purdie DM; Okai M; Maksoud A; Nieda M; Nicol AJ
Br J Cancer; 2004 Nov; 91(11):1880-6. PubMed ID: 15520823
[TBL] [Abstract][Full Text] [Related]
25. Expansion of Valpha24(+)Vbeta11(+) NKT cells from cord blood mononuclear cells using IL-15, IL-7 and Flt3-L depends on monocytes.
Okada H; Nagamura-Inoue T; Mori Y; Takahashi TA
Eur J Immunol; 2006 Jan; 36(1):236-44. PubMed ID: 16380959
[TBL] [Abstract][Full Text] [Related]
26. Reconstitution models to evaluate natural killer T cell function in tumor control.
Gebremeskel S; Slauenwhite D; Johnston B
Immunol Cell Biol; 2016 Jan; 94(1):90-100. PubMed ID: 26095148
[TBL] [Abstract][Full Text] [Related]
27. [Effects of humanized interleukin 21 on anti-leukemic activity of cytokine induced killer cells and the mechanism].
Zhao N; Zhao MF; Rajbhandary S; Lu WY; Zhu HB; Xiao X; Deng Q; Li YM
Zhonghua Xue Ye Xue Za Zhi; 2012 Oct; 33(10):823-8. PubMed ID: 23384903
[TBL] [Abstract][Full Text] [Related]
28. Effects of alpha-galactosylceramide (KRN7000), interleukin-12 and interleukin-7 on phenotype and cytokine profile of human Valpha24+ Vbeta11+ T cells.
Van Der Vliet HJ; Nishi N; Koezuka Y; Peyrat MA; Von Blomberg BM; Van Den Eertwegh AJ; Pinedo HM; Giaccone G; Scheper RJ
Immunology; 1999 Dec; 98(4):557-63. PubMed ID: 10594688
[TBL] [Abstract][Full Text] [Related]
29. Characterization of NKT cells in human peripheral blood and decidual lymphocytes.
Tsuda H; Sakai M; Michimata T; Tanebe K; Hayakawa S; Saito S
Am J Reprod Immunol; 2001 May; 45(5):295-302. PubMed ID: 11432404
[TBL] [Abstract][Full Text] [Related]
30. Temporal Regulation of Natural Killer T Cell Interferon Gamma Responses by β-Catenin-Dependent and -Independent Wnt Signaling.
Kling JC; Jordan MA; Pitt LA; Meiners J; Thanh-Tran T; Tran LS; Nguyen TTK; Mittal D; Villani R; Steptoe RJ; Khosrotehrani K; Berzins SP; Baxter AG; Godfrey DI; Blumenthal A
Front Immunol; 2018; 9():483. PubMed ID: 29616022
[TBL] [Abstract][Full Text] [Related]
31. Valpha24-JalphaQ-independent, CD1d-restricted recognition of alpha-galactosylceramide by human CD4(+) and CD8alphabeta(+) T lymphocytes.
Gadola SD; Dulphy N; Salio M; Cerundolo V
J Immunol; 2002 Jun; 168(11):5514-20. PubMed ID: 12023346
[TBL] [Abstract][Full Text] [Related]
32. Expansion of alpha-galactosylceramide-stimulated Valpha24+ NKT cells cultured in the absence of animal materials.
Harada Y; Imataki O; Heike Y; Kawai H; Shimosaka A; Mori S; Kami M; Tanosaki R; Ikarashi Y; Iizuka A; Yoshida M; Wakasugi H; Saito S; Takaue Y; Takei M; Kakizoe T
J Immunother; 2005; 28(4):314-21. PubMed ID: 16000949
[TBL] [Abstract][Full Text] [Related]
33. The in vitro proliferation and cytokine production of Vα24+Vβ11+ natural killer T cells in patients with systemic lupus erythematosus.
Yu XM; Wang XF
Chin Med J (Engl); 2011 Jan; 124(1):61-5. PubMed ID: 21362309
[TBL] [Abstract][Full Text] [Related]
34. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
[TBL] [Abstract][Full Text] [Related]
35. Transfer of mRNA Encoding Invariant NKT Cell Receptors Imparts Glycolipid Specific Responses to T Cells and γδT Cells.
Shimizu K; Shinga J; Yamasaki S; Kawamura M; Dörrie J; Schaft N; Sato Y; Iyoda T; Fujii S
PLoS One; 2015; 10(6):e0131477. PubMed ID: 26121617
[TBL] [Abstract][Full Text] [Related]
36. Changes in natural killer T cells subsets during therapy in type C hepatitis and hepatocellular carcinoma.
Okumura A; Ishikawa T; Maeno T; Sato K; Ayada M; Hotta N; Yamauchi T; Fukuzawa Y; Kakumu S
Hepatol Res; 2005 Aug; 32(4):213-7. PubMed ID: 15905121
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-15 enhances the expansion and function of natural killer T cells from adult peripheral and umbilical cord blood.
Lin SJ; Huang YC; Cheng PJ; Lee PT; Hsiao HS; Kuo ML
Cytokine; 2015 Dec; 76(2):348-355. PubMed ID: 26481260
[TBL] [Abstract][Full Text] [Related]
38. Dendritic cells are targets for human invariant Valpha24+ natural killer T-cell cytotoxic activity: an important immune regulatory function.
Nicol A; Nieda M; Koezuka Y; Porcelli S; Suzuki K; Tadokoro K; Durrant S; Juji T
Exp Hematol; 2000 Mar; 28(3):276-82. PubMed ID: 10720692
[TBL] [Abstract][Full Text] [Related]
39. Phenotypic and functional characterization of long-term cultured rhesus macaque spleen-derived NKT cells.
Gansuvd B; Hubbard WJ; Hutchings A; Thomas FT; Goodwin J; Wilson SB; Exley MA; Thomas JM
J Immunol; 2003 Sep; 171(6):2904-11. PubMed ID: 12960313
[TBL] [Abstract][Full Text] [Related]
40. Dendritic cell maturation by CD11c- T cells and Valpha24+ natural killer T-cell activation by alpha-galactosylceramide.
Ishikawa E; Motohashi S; Ishikawa A; Ito T; Uchida T; Kaneko T; Tanaka Y; Horiguchi S; Okamoto Y; Fujisawa T; Tsuboi K; Taniguchi M; Matsumura A; Nakayama T
Int J Cancer; 2005 Nov; 117(2):265-73. PubMed ID: 15900581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]